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Proteus syndrome is a rare overgrowth disorder including bone, soft tissue, 
and skin. Central nervous system manifestations were reported in about 40% 
of the patients including hemimegalencephaly and the resultant hemicranial 
hyperplasia, convulsions and mental deficiency. We report a 1-month-old male 
baby referred to Pediatric Neurology Clinic Soetomo Hospital, Surabaya, 
Indonesia in 2014 presented  recurrent seizures since birth with asymmetric 
dysmorphic face with the right side larger than the left, subcutaneous mass and 
linear nevi. Craniocervical MRI revealed hemimegalencephaly right cerebral 
hemisphere. Triple antiepileptic drugs were already given as well as the 
ketogenic diet, but the seizures persisted. The seizure then was resolved after 
hemispherectomy procedure.
Keywords: Intractable epilepsy; Linear nevi; Hemimegalencephaly; 
Hemispherectomy; Proteus syndrome
Introduction
Proteus syndrome is a rare overgrowth disorder affecting bone, soft tissue, and 
skin (1),  It is categorized as congenital neurocutaneous syndrome with initially 
unknown etiology. Clinical manifestations are highly variable, but usually affect 
the brain and other tissues. Main clinical signs are the overgrowth of the brain, 
skin abnormalities, hemihypertrophy, multiple hamartomatous tumors, gigantism 
of the extremities, and mental retardation. Brain imaging findings also vary, and 
may include calcifications, hemimegalencephaly, neuronal migration and callosal 
dysgenesis. Epilepsy and epileptic syndromes often occur as early onset and hard 
to control (1).
It is an extremely rare syndrome with a prevalence of approximately 1:1.000.000, 
more common among males at a ratio of 1.9:1 (2). The prognosis is poor due to 
the intractability of seizures (3). The rarity of the syndrome, the lack of an easily 
available diagnostic test, the wide spectrum of presentation, and the occurrence of the 
disease with unusual manifestation may contribute to the diagnostic challenge (2). 
The purpose of this case is to report a rare case of Proteus syndrome focusing on 
diagnosis and management of intractable seizures.
Case Report
MR, a 1-month-old male baby, was referred to Pediatric Neurology Clinic, Soetomo 
Hospital, Surabaya, Indonesia in 2014 with chief complaint of tonic spasm seizures 
CASE REPORT
87Iran J Child Neurol. SUMMER  2016  Vol 10 No 3
reported a patient with proteus syndrome, seen at the 
Emergency Department at 4 months of age, of a history 
of flexor spasms of the four extremities that started in 
the 2nd month of life at a frequency of 4–5 episodes/day. 
Sleep EEG revealed a high voltage burst suppression 
pattern with bursts lasting 1–3 s. Another patient started 
of seizures in the 2nd month of life was characterized by 
brief epileptic spasms of upper extremities. EEG showed 
a burst suppression pattern that lasted 3–5 s (4).
Patient also had asymmetric syndromic faces, 
hypertrophy of the right skull and right ear. The 
distinction of proportionate from disproportionate 
overgrowth is obvious by the age of two to three years but 
can be difficult to assess in infancy. The typical patient 
with Proteus syndrome essentially has a normal limb at 
birth, disfiguring overgrowth developing postnatally (5). 
We found the child with facial phenotype in Proteus 
syndrome. The facial phenotype in Proteus syndrome 
patients with mental retardation, in some cases, is with 
brain malformations and seizures already described by 
Cohen. Manifestations include dolichocephaly, long 
face, a high arched palate, minor down slanting of the 
palpebral fissures and or minor ptosis, an open mouth 
at rest, wide or anteverted nares, and low nasal bridge 
(6,7).
In the right cheek and neck, we found subcutaneous 
mass covered by linear nevy partly. Lipomas in 
Proteus syndrome are composed principally of mature 
adipocytes, and lipomas may be infiltrative or confined. 
Even though histopathologic finding always describes 
benign adipose tissue cells, the location of lesions is of 
great importance (6). They are typically unencapsulated 
fatty and fibrous masses with vascular channels, often 
lymphangiomatous (1).
Craniocervical MRI with contrast revealed 
hemimegalencephaly right cerebral hemisphere. There 
was no specific molecular marker, or laboratory test, for 
the diagnosis of Proteus syndrome (2). The diagnosis 
is mainly based on history, clinical judgment and 
neuroimaging modality  (Table 1). The diagnosis of 
Proteus syndrome requires all three general criteria, 
plus one criterion from category A, or two criteria from 
category B, or three criteria from category C, although 
many manifestations had been recorded (7, 8).
In this case, we did not find the cerebriform connective 
since birth and recently became more frequent. Seizures 
often occurred after he woke up. No family history of 
seizure was recorded. He was delivered by caesarean 
section due to cephalo-pelvic disproportion with 
gestational age 38 weeks and 3400 gr of birth weight. 
Written informed consent was obtained from the parents.
Physical examination revealed an alert boy with 
4300 gr of body weight. There were asymmetric 
dysmorphic face, hypertrophy of right skull and right 
ear, subcutaneous mass 5x6x7 cm in the right cheek and 
neck with the presence of linear nevi. We observed the 
patient with nystagmus, a high-arched palate, including 
an elongated face and low nasal bridge. Biopsy from the 
right cheek mass revealed no evidence of malignancy, 
and the conclusion was a lipoma. 
Craniocervical MRI with contrast revealed 
hemimegalencephaly right cerebral hemisphere with 
the features of pachygyria and lipoma of the right 
facial leading to anencephalic cutaneous lipomatosis 
(Proteus Syndrome); multiple congenital deformity with 
the feature of left cerebral hemisphere hemiatrophy, 
hypoplasia of the posterior corpus callosum and closed 
lip schizencephalic; non-enhancing septated cystic lesion 
of right infra-auricular led to hygroma colli (fig 2).
EEG described PLEDs in the right frontal region; 
asymmetry decreased background rhythm in the 
right frontotemporal, burst suppression in the right 
frontotemporal (fig 3). 
The patient still suffered from recurrent seizures with 
maximal doses of three kinds of antiepileptic drugs 
and the ketogenic diet. The patient was consulted to 
neurosurgery and hemispherectomy was performed 
by an anterior horn to posterior horn corticotomy, 
callosotomy and right anterior temporal lobectomy, 
cortical insulectomy, anterior disconnection and found 
brain dysplasia. After hemispherectomy procedure, the 
patient was fully conscious, no seizures or paralysis of 
limbs. Seizure medication was gradually changed to oral 
with one type of drug, i.e., valproic acid. 
Discussion
In our case, the patient suffered from seizures since the 
1st day of life and recently became more frequent. The 
EEG showed burst suppression pattern that considered 
severe epileptic encephalopathy (3). Bastos et al, 
Proteus syndrome
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in seizure control, quality of life, and development (10).
In conclusion, a rare case of Proteus syndrome was 
reported. The patient presented with intractable seizures 
and did not respond to triple antiepileptic drugs. 
Hemispherectomy was performed to overcome the 
seizures. After the procedure, the patient was seizure 
free. The prognosis was poor.
tissue nevus. The cerebriform connective tissue nevus 
was not found at birth but usually appeared during 
the first or second year of life and was progressive. 
Cerebriform connective tissue nevus and lipomas were 
defined under a group consisting of postnatal lesions 
with a delayed onset and progressive course (8). It is 
unknown if these lesions have an accelerated growth 
during puberty (1).
Various syndromes considered in differential diagnosis 
are grouped for convenience as vascular syndromes, 
syndromes with pigmentation, and lipomatosis, include 
Klippel-Trenaunay syndrome, Hemihyperplasia/ 
lipomatosis syndrome, Parks Weber syndrome, Maffucci 
syndrome, Neurofibromatosis type 1, Epidermal 
nevus syndrome, Familial lipomatosis, Symmetrical 
Lipomatosis, Encephalocraniocutaneus lipomatosis (8).
The patient had hemispherectomy procedure by 
callosotomy and right anterior temporal lobectomy, 
cortical insulectomy, anterior disconnection and 
presented brain dysplasia. Seizures associated with 
hemimegalencephaly are difficult to treat totally. Some 
reports of intractable seizure in Proteus syndrome 
treated with polytherapy of oral antiepileptic agents (4). 
Hemispherectomy has been used in several series to 
control effectively seizures (9).
After hemispherectomy surgery, the patient was fully 
conscious, no seizures or paralysis of limbs. Good 
results of hemispherectomy in pediatric patients with 
refractory epilepsy, not only in terms of seizure control 
but also in terms of motor and cognitive functions. 
Moosa et al, stated that 73.5% patients became seizure 
free, and 13.5% had a reduction in seizure frequency. 
Although hemispherectomy produced expected 
postsurgical deficits, patients had reported an important 
improvement of quality of life, and in many patients the 
antiepileptic drugs could be discontinued or reduced 
(10).
Six weeks follow up after being discharged showed that 
the patient in a good condition. There were no seizure or 
paralysis of the limb, being able to a self-prone position 
but could not lift his head. The long-term seizure-free 
rates after hemispherectomy remained stable at 63% 
at five years and beyond (9). Quality-of-life measures 
paralleled seizure outcomes. Epilepsy surgery in children 
with intractable epilepsy can produce significant result 
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Fig 1. Clinical picture showing asymmetric dysmorphic 
face, subcutaneous mass and presence of linear nevi
Fig 2. MRI showing hemimegaleencephaly 
89Iran J Child Neurol. SUMMER  2016  Vol 10 No 3
Acknowledgement
We are thankful for Wihasto Suryaningtyas’s help in 
managing the patient.
Author’s contribution
Prastiya Indra GUNAWAN: design of the case, review 
literature, managing and analyzing the case, drafting the 
case.
Lusiana Lusiana: managing the case and completing 
the data.
Proteus syndrome
Darto SAHARSO: editing and supervised and final 
approval of the case
All authors agreed to be accountable for all aspects 
of the work in ensuring that questions related to the 
accuracy or integrity of any part of the work are 
appropriately investigated and resolved.
Conflict of interest
The authors declare there is no conflict of interest  







Cerebriform connective tissue nevus
Category B
Linear epidermal nevus
Asymmetric, disproportionate overgrowth of two of:
Limbs, skull, external auditory canal, vertebrae, or viscera






Capillary, venous, and/or lymphatic
Lung bullae
Facial phenotype:
Long face, dolichocephaly, down-slanted palpebral fissures, low nasal bridge, wide or anteverted nares, open 
mouth at rest
Source: Biesecker LG, Happle R, Mulliken JB, Weksberg R, Graham JM, Jr., Viljoen DL, et al. Proteus syndrome: diagnostic 
criteria, differential diagnosis, and patient evaluation. Am J Med Genet. 1999;84:389-95.8 ( add to references)
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Fig 3. EEG showing PLEDs in the right frontal region and burst suppression in the right fronto 
temporal 
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